Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan
· Delayed Price · Currency is JPY 2,183.00
-23.00 (-1.04%)
Mar 10, 2025, 3:30 PM JST
Zeria Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | - | 9,508 | 7,272 | 5,721 | 3,922 | 3,920 | Upgrade
|
| Depreciation & Amortization | - | 7,555 | 6,148 | 5,399 | 4,435 | 3,943 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 32 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -499 | -19 | -14 | -375 | -44 | Upgrade
|
| Other Operating Activities | - | -906 | -530 | -864 | -512 | -1,005 | Upgrade
|
| Change in Accounts Receivable | - | -2,075 | -171 | -2,029 | 825 | 1,573 | Upgrade
|
| Change in Inventory | - | -863 | -150 | -542 | -753 | 456 | Upgrade
|
| Change in Accounts Payable | - | 1,052 | -207 | 284 | -40 | -174 | Upgrade
|
| Change in Other Net Operating Assets | - | -1,589 | 814 | 995 | -640 | -1,418 | Upgrade
|
| Operating Cash Flow | - | 12,183 | 13,157 | 8,950 | 6,894 | 7,251 | Upgrade
|
| Operating Cash Flow Growth | - | -7.40% | 47.01% | 29.82% | -4.92% | 31.84% | Upgrade
|
| Capital Expenditures | - | -2,900 | -2,400 | -1,064 | -734 | -622 | Upgrade
|
| Cash Acquisitions | - | -623 | - | - | -2,464 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -998 | -257 | -356 | -15,398 | -651 | Upgrade
|
| Investment in Securities | - | 473 | 58 | -1,477 | 1,173 | 807 | Upgrade
|
| Other Investing Activities | - | 96 | 25 | 5 | -37 | 61 | Upgrade
|
| Investing Cash Flow | - | -3,952 | -2,574 | -2,892 | -17,460 | -405 | Upgrade
|
| Short-Term Debt Issued | - | - | 279 | - | 12,744 | 1,401 | Upgrade
|
| Long-Term Debt Issued | - | 500 | 500 | 16,158 | 4,500 | 500 | Upgrade
|
| Total Debt Issued | - | 500 | 779 | 16,158 | 17,244 | 1,901 | Upgrade
|
| Short-Term Debt Repaid | - | -560 | - | -13,241 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -5,778 | -5,628 | -3,388 | -3,122 | -2,666 | Upgrade
|
| Total Debt Repaid | - | -6,338 | -5,628 | -16,629 | -3,122 | -2,666 | Upgrade
|
| Net Debt Issued (Repaid) | - | -5,838 | -4,849 | -471 | 14,122 | -765 | Upgrade
|
| Repurchase of Common Stock | - | - | -673 | -2,603 | -1,154 | -3,289 | Upgrade
|
| Dividends Paid | - | -1,935 | -1,590 | -1,538 | -1,568 | -1,597 | Upgrade
|
| Other Financing Activities | - | -351 | -303 | -229 | -215 | -226 | Upgrade
|
| Financing Cash Flow | - | -8,124 | -7,415 | -4,841 | 11,185 | -5,877 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 2,402 | 1,346 | 564 | 169 | -52 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 1 | - | 128 | - | 42 | Upgrade
|
| Net Cash Flow | - | 2,510 | 4,514 | 1,909 | 788 | 959 | Upgrade
|
| Free Cash Flow | - | 9,283 | 10,757 | 7,886 | 6,160 | 6,629 | Upgrade
|
| Free Cash Flow Growth | - | -13.70% | 36.41% | 28.02% | -7.07% | 50.25% | Upgrade
|
| Free Cash Flow Margin | - | 12.26% | 15.73% | 13.25% | 11.11% | 10.97% | Upgrade
|
| Free Cash Flow Per Share | - | 210.59 | 243.52 | 174.70 | 133.70 | 141.91 | Upgrade
|
| Cash Interest Paid | - | 446 | 300 | 304 | 223 | 232 | Upgrade
|
| Cash Income Tax Paid | - | 915 | 564 | 874 | 526 | 1,004 | Upgrade
|
| Levered Free Cash Flow | - | 7,850 | 8,807 | 6,071 | -12,962 | 10,211 | Upgrade
|
| Unlevered Free Cash Flow | - | 8,136 | 9,017 | 6,268 | -12,813 | 10,354 | Upgrade
|
| Change in Net Working Capital | -552 | 1,535 | 108 | 1,690 | 3,268 | -5,178 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.